Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 1.58B P/E - EPS this Y 66.70% Ern Qtrly Grth -
Income 95.69M Forward P/E -211.00 EPS next Y 400.00% 50D Avg Chg -56.00%
Sales 346.72M PEG - EPS past 5Y - 200D Avg Chg -38.00%
Dividend N/A Price/Book 53.28 EPS next 5Y - 52W High Chg -70.00%
Recommedations 2.10 Quick Ratio 2.77 Shares Outstanding 154.82M 52W Low Chg 117.00%
Insider Own 9.59% ROA 20.47% Shares Float 133.47M Beta 2.21
Inst Own 61.05% ROE 87.78% Shares Shorted/Prior 29.84M/32.72M Price 10.55
Gross Margin 92.76% Profit Margin 27.60% Avg. Volume 4,329,672 Target Price 34.29
Oper. Margin 12.00% Earnings Date Oct 30 Volume 12,845,372 Change 0.57%
About TG Therapeutics, Inc.

TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally. It provides BRIUMVI, an anti-CD20 monoclonal antibody for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease in adults. The company's development pipeline comprises Umbralisib, an oral inhibitor of PI3K-delta inhibitor for the treatment of adult patients with relapsed or refractory marginal zone lymphoma and follicular lymphoma; TG-1701 is an orally available and covalently bound Bruton's tyrosine kinase (BTK) inhibitor that exhibits selectivity to BTK in vitro kinase screening; and TG-1801, a bispecific CD47 and CD19 antibody. Its research pipeline includes various investigational medicines. The company has license agreements with LFB Biotechnologies S.A.S; GTC Biotherapeutics; LFB/GTC LLC; Ildong Pharmaceutical Co. Ltd.; Rhizen Pharmaceuticals, S A. for the development and commercialization of umbralisib; Jiangsu Hengrui Medicine Co.; and Novimmune SA, as well as collaboration agreement with Checkpoint Therapeutics, Inc. for the development and commercialization of anti-PD-L1 and anti-GITR antibody research programs in the field of hematological malignancies. TG Therapeutics, Inc. was incorporated in 1993 and is based in Morrisville, North Carolina.

TG Therapeutics, Inc. News
05:02 AM High Growth Tech Stocks to Watch in October 2024
09/20/24 TG Therapeutics Inc (TGTX): Short Seller Sentiment is Bearish
09/19/24 Are Robust Financials Driving The Recent Rally In TG Therapeutics, Inc.'s (NASDAQ:TGTX) Stock?
09/18/24 IBD 50's TG Therapeutics Rises On Five-Year Data For Multiple Sclerosis Drug
09/18/24 Stocks Reverse Lower After Fed's Half-Point Rate Cut; Donald Trump Stock Slammed Again (Live Coverage)
09/18/24 New BRIUMVI® (ublituximab-xiiy) Data from the ENHANCE Phase 3b Study Show Rapid 30-Minute Infusions are Well Tolerated in Patients with Relapsing Forms of Multiple Sclerosis
09/18/24 New Data for BRIUMVI® (ublituximab-xiiy) Demonstrate that 92% of Patients with Relapsing Multiple Sclerosis Were Free from Disability Progression After 5 Years of Treatment
09/06/24 Palantir Technologies, Dell Technologies, and Erie Indemnity Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600
09/06/24 Four Biotech Stocks Rally Toward Buy Points As Funds Load Up
09/05/24 TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI at the 2024 European Committee for Treatment and Research in Multiple Sclerosis Annual Meeting
08/30/24 TG Therapeutics Inc (NASDAQ:TGTX) A Bull Case Theory
08/23/24 High Growth Tech Stocks in the United States to Watch
08/19/24 IBD 50 Stock TG Therapeutics Breaks Out Bullishly After 'Solid' Quarter
08/16/24 IBD Stock Of The Day TG Therapeutics Flirts With Two Breakouts On Its Newfound Profitability
08/12/24 FDA grants IND clearance for TG Therapeutics’ trial of multiple sclerosis treatment
08/09/24 Results: TG Therapeutics, Inc. Confounded Analyst Expectations With A Surprise Profit
08/06/24 TG Therapeutics Stock Rockets As Surprise Profit Smashes Views By 157%
08/06/24 TG Therapeutics (TGTX) Surpasses Q2 Earnings and Revenue Estimates
08/06/24 TG Therapeutics: Q2 Earnings Snapshot
08/06/24 TG Therapeutics Reports Second Quarter 2024 Financial Results and Raises BRIUMVI® (ublituximab-xiiy) Full Year Revenue Guidance
TGTX Chatroom

User Image Erod70 Posted - 19 minutes ago

$TGTX LFGO!!! Short bbq!!! 🔥🔥🔥🔥🦍😎💪😎

User Image ern1in Posted - 23 minutes ago

$TGTX @Pennzwoods Made a good call ! Good eye, Soldier ! HUMAN / "WEREWOLF" / WILD BOAR > TGTX HYBRID SOLDIER .....

User Image kingjd31 Posted - 51 minutes ago

$TGTX should rip tm

User Image ern1in Posted - 1 hour ago

$TGTX 🤔

User Image Pennzwoods Posted - 1 hour ago

$TGTX Interesting start to the week. Shorts took that 500k back out this mornin'. No surprise there. Which has me wondering when and where the hit will be. 23.35 or 22.85? Will they drop it hard and low with an immediate cover.(likely) The morning open may be interesting. I am not being bearish just looking to pattern. Their not stepping hard on the uptick today has me leaning toward letting it break 23 before the hit. Then again it could have just been covering on a vague bo rumor.(nah) Which a buy out was announced just not us. Did somebody jump the gun? Doubtful, not with 500k sharers. I'm leaning toward suitor(s) playing games. Truth is it could be any number of variables. But time is ticking down. btw 23 and a quarter m/l hit to 21.65+/- if they don't tag it at the bell.

User Image ern1in Posted - 2 hours ago

$TGTX @Pennzwoods : Will Magenta approve the TGTX / HYBRID SOLDIER MOVEMENT ? I don't get it ? Is that Magenta's sister ? Is she speaking in code ? 🤔

User Image USMAgrad Posted - 2 hours ago

$TGTX Look at those pretty green candles w nice long sticks on top! Tomorrow should be another fun day! Just wish there was more volume😬

User Image ern1in Posted - 2 hours ago

$TGTX This rock band video just surfaced. > HYBRID TGTX SOLDIERS . 1/2 HUMAN / 1/2 WILD BOAR 🐗 ...... Footage rarely seen. Next venture. .... 1/2 hyena / 1/2 human.

User Image ern1in Posted - 2 hours ago

$TGTX This is for @Pennzwoods ..... 😝😝😝😝😝😝😝😝😝😝

User Image Mmiddleb Posted - 3 hours ago

$TGTX one day, we will wake up and the price will be four times what it is today

User Image WirthM13 Posted - 3 hours ago

$TGTX Whenever I'm tempted to sell or swing trade some of my TG shares, this is my nightmare. June $18, today Oct 14 $59. @RonIsWrong Good sportsmanship! I hope your TG shares serve you better!

User Image Ninja_of_Aces Posted - 3 hours ago

$LBPH $TGTX self proclaimed technical gurus love to share random opinions like this one on LBPH. Then cry when they get it wrong. TG bears gonna go down the same way. This one really didn’t age well did it? 😂🤣🤣

User Image Believe2 Posted - 3 hours ago

$TGTX APARNA NARAYANAN04:26 PM ET 10/14/2024 Investors looking to supercharge their portfolios often benefit from a broader stock search. One simple way to do that is to look at year-ahead earnings forecasts. Our hunt for the seven best stocks poised for magnificent earnings growth next year brought up names such as TG Therapeutics (TGTX) and RadNet (RDNT) — stocks far less obvious than Nvidia (NVDA), Meta (META), Apple (APPL) or the other megacap leaders that dominate the market. Biotech Companies Among Best Stocks TG Therapeutics (TGTX): A commercial-stage biopharmaceutical company, TG sells a multiple sclerosis treatment called Briumvi. Analysts forecast TG will see a 1,316% earnings-per-share surge in 2025, recovering from a sharp decline this year. The company has made a recent turn to profits. Sales are seen growing 41% in 2024 and 49% in 2025. TG Therapeutics stock shows a Composite Rating of 93 and RS Rating of 97. I from Investors Business Daily

User Image RookieRider Posted - 4 hours ago

$TGTX This Sh*t Looks good and I’m not even a Chartass…LFGO 👍🏻😎

User Image Kyle_99 Posted - 4 hours ago

$TGTX gimme $24 tomorrow

User Image SteeCo Posted - 4 hours ago

$TGTX this close above SMA 50 today is very solid and emphasized that the bullish trend is intact. Forget about the clowns here claiming we go down. Up we go! Why? Because if you get 60$ worth for 22.8$ you just take it.

User Image Chartist0_0 Posted - 4 hours ago

$TGTX I don't care if the short interest has been high for a while now, I'd still like to know what it's still high. I mean, if they have a convertible debt outstanding, that would help explain it. But I find it very curious considering that the drug is approved and selling.

User Image WeAreKangz Posted - 4 hours ago

$TGTX absolutely excellent green candle volume on those last 10 minutes. Rock solid close! Looking forward to this riding is xbi will try for 103 again

User Image Max22 Posted - 4 hours ago

For some reason i took your answer as if you were talking about $DJT. Got mixed up, my bad. You're writing for $TGTX.

User Image USMAgrad Posted - 4 hours ago

$TGTX It’s been a rough couple of weeks but today feels NIIIIICE!🎉 🖕🏻 shorts!

User Image Fuhk_it_im_banned_again Posted - 4 hours ago

$TGTX wait…did I miss $11?

User Image Vax_Ryder Posted - 4 hours ago

$TGTX to all the haters

User Image BioAmerica Posted - 4 hours ago

$TGTX Just for fun...how many would be happy with a $52 BO after hours today? And part 2, if you are not happy with that, how much would it take to make you happy?

User Image Erod70 Posted - 4 hours ago

$TGTX but wait…the chart says..😂🦍😎💪😎

User Image Chartist0_0 Posted - 5 hours ago

$TGTX I haven't seen one person even try to do a discounted cash flow valuation model on this. And it's odd cuz it seems most of you are holding this for some kind of buyout.

User Image ern1in Posted - 5 hours ago

$TGTX 🤔🕶🎼🦉

User Image Buyaa Posted - 5 hours ago

$TGTX - The shorts better cover in next ~ 45 mins. Today LBPH got bought out, tomorrow it very well could be TGTX. Short fellowmen don't play with fire and be greedy for few cents. Go Long until it's bought out.

User Image StocksInTheGreen Posted - 5 hours ago

$TGTX I thought we were headed for $12…….??? Clowns

User Image kingjd31 Posted - 5 hours ago

$TGTX

User Image Diefreeandsell Posted - 6 hours ago

$TGTX $26 by Friday! Getting closer running stronger!

Analyst Ratings
HC Wainwright & Co. Buy Sep 18, 24
B. Riley Securities Buy Aug 7, 24
Goldman Sachs Neutral Aug 7, 24
HC Wainwright & Co. Buy Aug 6, 24
HC Wainwright & Co. Buy May 2, 24
Ladenburg Thalmann Buy May 2, 24
HC Wainwright & Co. Buy Apr 18, 24
JP Morgan Overweight Apr 18, 24
Ladenburg Thalmann Buy Apr 18, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Charney Laurence N Director Director Jan 05 Sell 19.03 17,500 333,025 237,229 01/08/24
Power Sean A CFO CFO Jan 03 Sell 16.91 47,867 809,431 606,969 01/05/24
WEISS MICHAEL S CEO and President CEO and President Aug 11 Buy 10.13 100,000 1,013,000 12,073,021 08/14/23
Lonial Sagar Director Director Jun 23 Sell 23.370 34,854 814,538 93,878 06/26/23
Power Sean A Chief Financial Offi.. Chief Financial Officer Jun 02 Sell 26.70 73,647 1,966,375 654,836 06/05/23
Echelard Yann Director Director Jan 06 Buy 10.64 9,000 95,760 201,848 01/06/23
Charney Laurence N Director Director Jan 04 Sell 11.10 30,000 333,000 234,729 01/06/23
Power Sean A CFO, Secretary and T.. CFO, Secretary and Treasurer Jan 04 Sell 18.76 84,965 1,593,943 568,483 01/07/22
WEISS MICHAEL S CEO and President CEO and President Dec 29 Sell 18.76 68,220 1,279,807 10,988,021 01/07/22